{"id":16192,"date":"2025-04-10T14:12:20","date_gmt":"2025-04-10T14:12:20","guid":{"rendered":"https:\/\/dev.haugpartners.com\/?post_type=article&#038;p=16192"},"modified":"2025-04-10T19:39:59","modified_gmt":"2025-04-10T19:39:59","slug":"regeneron-pharmaceuticals-inc-v-mylan-pharmaceuticals-inc-et-al","status":"publish","type":"article","link":"https:\/\/haugpartners.com\/article\/regeneron-pharmaceuticals-inc-v-mylan-pharmaceuticals-inc-et-al\/","title":{"rendered":"Federal Circuit Affirms Presumption of Separateness in <i>Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al.,<\/i> C.A. No. 24-2351 (Fed. Cir. Mar. 14, 2025)"},"featured_media":0,"template":"","categories":[101],"acf":[],"_links":{"self":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/article\/16192"}],"collection":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/article"}],"about":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/types\/article"}],"wp:attachment":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/media?parent=16192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/categories?post=16192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}